Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(15/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(15/week)
News
United States
(645/week)
Manufacturing
(442/week)
Energy
(369/week)
Technology
(457/week)
Other Manufacturing
(373/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
U.S. Food and Drug Administration (FDA)
Dec 15, 2020
binx health receives EUA authorizing At-Home COVID-19 sample collection by universities and employers
Jan 30, 2020
Cardinal Health announces voluntary field actions for select procedure packs containing affected surgical gowns
Dec 06, 2019
ASH and FDA Unveil New Recommendations to Guide Clinical Development of Sickle Cell Disease Therapies
Nov 05, 2019
FDA Awards AnaBios Contract to Obtain Critical Translational Data from Ex Vivo Human Cardiac Platform
Jun 07, 2019
PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years of Age
Mar 27, 2019
Soliton Receives FDA Acceptance for 510(k) Application
Jul 02, 2018
FDA Approves ARISTADA INITIO(TM) for the Initiation of ARISTADA® for Schizophrenia
Jun 25, 2018
IMBRUVICA® (ibrutinib) Supplemental New Drug Application Accepted for Review by U.S. FDA with Potential to Broaden Treatment Use as a Combination Treatment Option with Rituximab in Waldenström's Macroglobulinemia (WM), A Rare Form of Blood Cancer
Dec 11, 2017
People Aged 75 Years and Older Are Underrepresented in Blood Cancer Clinical Trials
Nov 13, 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Sep 14, 2017
FDA Not Currently Planning to Hold Advisory Committee Meeting for BioMarin's Pegvaliase Biologics License Application (BLA)
Aug 30, 2017
LLS Investment Pays Off: FDA Approves Revolutionary Immunotherapy for Blood Cancer Patients
Aug 29, 2017
FDA Accepts BioMarin's Pegvaliase Biologics License Application (BLA) and Grants Priority Review Designation
Aug 03, 2017
The Leukemia & Lymphoma Society Applauds Another Advance for Blood Cancer Patients
Jul 26, 2017
FDA Approves Eisai's FYCOMPA® (perampanel) for Use as Monotherapy for the Treatment of Partial-Onset Seizures
Latest News
May 9, 2024
Cotchett, Pitre & McCarthy Mourns the Loss of Former Congressman Pete McCloskey
May 9, 2024
DXP Enterprises, Inc. Reports First Quarter 2024 Results
May 9, 2024
Stelco Holdings Inc. Reports First Quarter 2024 Results
May 9, 2024
Hess Midstream Operations LP Announces Pricing of Upsized Private Offering of Senior Notes Due 2029
May 9, 2024
Altius Reports Q1 2024 Attributable Royalty Revenue of $17.4M and Adjusted Earnings(1) of $3.5M
May 9, 2024
SunOpta Announces First Quarter Fiscal 2024 Financial Results
May 9, 2024
Atmos Energy Corporation Reports Earnings for Fiscal 2024 Second Quarter; Raises Fiscal 2024 Guidance
May 9, 2024
Atmos Energy Declares Regular Quarterly Dividend
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events